Showing results (291-300 of 344) with videos related to

Sort By:
Pageof 35
Journal of Endocrinological Investigation|October 1, 1987
Effects of thyroid stimulating immunoglobulin on function and morphology of xenotransplanted toxic diffuse, toxic nodular and normal thyroid tissueE Jörtsö, J Mölne, B Boeryd, et al.
Plos One|May 30, 2020
Association of vitamin A deficiency with early childhood stunting in Uganda: A population-based cross-sectional studyPaddy Ssentongo, Djibril M Ba, Anna E Ssentongo, et al.
Cancer Research|January 22, 2009
Transient receptor potential type vanilloid 1 suppresses skin carcinogenesisAnn M Bode, Yong-Yeon Cho, Duo Zheng, et al.
Plos One|April 8, 2021
Correction: Association of vitamin A deficiency with early childhood stunting in Uganda: A population-based cross-sectional studyPaddy Ssentongo, Djibril M Ba, Anna E Ssentongo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 28, 2011
Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathwaysJixia Li, Yeon-Yong Cho, Alyssa Langfald, et al.
Therapeutic Drug Monitoring|January 13, 2017
A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal TransplantationJessica E Ericson, Kanecia O Zimmerman, Daniel Gonzalez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Human Paenibacillus Infections: A Systematic Review with Comparison of Adult and Infant CasesDanielle Smith, Kristen Bastug, Kathy Burgoine, et al.
The Journal of Investigative Dermatology|August 17, 2006
Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significanceEva M J Peters, Marna E Ericson, Junichi Hosoi, et al.
Molecular Cancer Therapeutics|April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changesRonald A Lubet, Eva Szabo, Konstantin Christov, et al.
Cancer Research|October 15, 1993
E-cadherin: a differentiation marker in thyroid malignanciesG Brabant, C Hoang-Vu, Y Cetin, et al.
Pageof 35